Keyphrases
Peripheral Neuropathy
42%
Chemotherapy-induced Peripheral Neuropathy
42%
Axonal Degeneration
36%
Rodents
30%
SARM1
27%
Paclitaxel-induced Peripheral Neuropathy
24%
Calpain Activity
24%
Peripheral Nerve Injury
24%
Pathological Features
24%
Nerve
24%
Schwann
24%
Triamcinolone Acetonide
24%
Structure Feature
24%
Morphological Profiling
24%
Cisplatin-induced
24%
Muscle Stem Cell (MuSC)
24%
Neurotoxicity
24%
Upper Extremity
24%
Paclitaxel
18%
Pathological Characteristics
12%
Vascular Component
12%
Differential Diagnosis
12%
Element Components
12%
Myelinated
12%
Cancer Cells
12%
Cisplatin
12%
Myelin
12%
In Cancer
12%
Blood Vessels
12%
Peripheral Nerve Defect
12%
Interstitial Space
12%
Pathological Process
12%
Nerve Pathology
12%
Neuropathy
12%
Myelinated Nerve Fibers
12%
Axon
12%
Vincristine-induced Neuropathy
9%
Dorsal Root Ganglion Neurons
6%
Axonal Dysfunction
6%
Cancer Drugs
6%
Chemotherapy Agents
6%
Antitumor Activity
6%
Cytotoxicity
6%
Therapeutic Candidates
6%
Phenotypic Drug Screening
6%
Neuroprotective Drugs
6%
Symptomatic Therapy
6%
Mouse Model
6%
Adduct Formation
6%
Cancer Cell Lines
6%
Neuroscience
Peripheral Neuropathy
100%
Nerve Fiber Degeneration
89%
Neurotoxicity
73%
Axonal Degeneration
55%
Axon
49%
Peripheral Neuropathy
28%
Nerve Cell Differentiation
24%
Cisplatin
24%
Vincristine
24%
Stem Cell
24%
Bortezomib
24%
Calpain
24%
Peripheral Nerve Injury
24%
In Vitro
21%
Dorsal Root Ganglion
17%
Myelin
12%
Neurite Outgrowth
12%
Myelinated Nerve Fiber
12%
Nervous System Function
12%
Differential Diagnosis
12%
Nerve Cell Degeneration
12%
Wallerian Degeneration
10%
Neuroprotective Agent
9%
In Vivo
7%
Schwann Cell
6%
Cytotoxicity
6%
Pharmacology, Toxicology and Pharmaceutical Science
Peripheral Neuropathy
42%
Chemotherapy-Induced Peripheral Neuropathy
39%
Paclitaxel
29%
Malignant Neoplasm
26%
Fluocinolone Acetonide
24%
Ethoxyquin
24%
Cisplatin
24%
Neurotoxicity
24%
Calpain
24%
Nerve Fiber Degeneration
20%
Side Effect
15%
Neuroprotective Agent
14%
Mouse
11%
Mouse Model
9%
Drug Screening
9%
Chemotherapy Agent
6%
Cytotoxicity
6%
Calpastatin
6%
Wallerian Degeneration
6%